LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
April 30, 2024 07:00 ET
|
LSL Pharma Group Inc.
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023 of...
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
April 24, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, April 24, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the...
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
April 23, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, April 23, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the...
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million
April 11, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Québec, April 11, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced...
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
April 09, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, , April 09, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced today that it...
Gestion Jacques Grimard Inc. acquiert des unités de Groupe LSL Pharma Inc.
March 19, 2024 18:45 ET
|
Groupe LSL Pharma Inc.
BOUCHERVILLE, Québec, 19 mars 2024 (GLOBE NEWSWIRE) -- Gestion Jacques Grimard Inc. (l’« Acquéreur ») annonce qu’il a acquis le 18 mars 2024 la propriété de 4 692 500 unités de LSL au prix de...
Le Groupe LSL Pharma clôture un financement de 6,44 millions $ comme première tranche de placements privés concomittants sans courtier
March 19, 2024 07:00 ET
|
Groupe LSL Pharma Inc.
Produits en espèces de 2,7 millions $, dont 0,4 million $ provenant d'initiés Conversion de dettes totalisant 3,75 millions $ BOUCHERVILLE, Québec, 19 mars 2024 (GLOBE NEWSWIRE) -- GROUPE...
LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements
March 19, 2024 07:00 ET
|
LSL Pharma Group Inc.
$2.7M cash investments secured including $0.4M from Insiders $3.75M of Debt converted BOUCHERVILLE, Quebec, March 19, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation"...
Le groupe LSL Pharma annonce une combinaison de placements privés pour un produit brut total maximum de 8 millions $
March 07, 2024 07:00 ET
|
Groupe LSL Pharma Inc.
Jusqu’à 3,5 millions $ de produits en espècesJusqu'à 4,5 millions $ en conversion de dettesLes produits du financement serviront à augmenter la capacité de production BOUCHERVILLE, Québec, 07...
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million
March 07, 2024 07:00 ET
|
LSL Pharma Group Inc.
Up to $3.5 M in cash proceedsUp to $4.5 M in debts conversion Proceeds to be used to further expand production capacity BOUCHERVILLE, Québec, March 07, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA...